In prostate cancer, decreased expression of annexin A4 has been shown to correlate with worsen pathological stage (Xin et al, 2003), and loss of annexin A7 has been associated with metastatic and local recurrences of hormone refractory prostate cancer (Srivastava et al, 2001). Here, ANXA7 is linked to prostate carcinoma.